RIGL Total Non-Current Liabilities
Rigel Pharmaceuticals Inc · Total Non-Current Liabilities
RIGL Total Non-Current Liabilities
Latest reported$22.88Mperiod ending
RIGL FY Total Non-Current Liabilities ($6.89M → $22.88M)
Annual total non-current liabilities
High-resolution chart · PNG
RIGL total non-current liabilities history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Non-Current Liabilities (USD) |
|---|---|
| 22,877,000 | |
| 97,389,000 | |
| 92,602,000 | |
| 82,684,000 | |
| 73,400,000 | |
| 35,511,000 | |
| 35,542,000 | |
| 1,498,000 | |
| 128,000 | |
| 519,000 | |
| 6,570,000 | |
| 11,864,000 | |
| 7,513,000 | |
| 8,743,000 | |
| 9,430,000 | |
| 9,238,000 | |
| 13,104,000 | |
| 15,542,000 | |
| 17,495,000 | |
| 14,773,000 | |
| 15,433,000 | |
| 15,103,000 | |
| 7,497,000 | |
| 4,531,000 | |
| 7,345,000 | |
| 7,196,000 | |
| 6,893,000 |